Ellen AB:s tredje patentfamilj godkänd i USA
PRESS RELEASE 19 November 2007 Ellen AB's third patent family approved in the USA The US authorities have approved Ellen AB's patent for five unique lactic acid bacteria strains that can promote women's vaginal health. “This means that as of now, US players are also prevented from using our bacteria strains for commercial purposes. Our products are protected in the USA up to and including 2021,” comments Anna Weiner Jiffer, co-founder of Ellen AB. The company has submitted a global patent application which has to date been approved in Sweden, South Africa, Australia, China, Singapore and now the USA. The international launch of the company's first product, the probiotic tampon ELLEN®, has begun. After cementing the tampon's position on the Swedish and Nordic markets, the first non-Nordic launch was carried out at the start of 2007 in France, followed by a launch in Austria during the third quarter. Ellen AB is concurrently working to develop new products based on the same patented technology. Ellen AB has a strong patent portfolio. The bacteria strains have good clinical effects, capacity for large-scale fermentation, survive longer in a freeze-dried state and are stable generation to generation. Ellen AB's first patent family, secured as early as 1992, is for probiotic sanitary protection products. The second patent family, approved by the European Patent Office, protects the production methods for probiotic sanitary protection products up until 2020. A global application has been registered for this patent which also been approved in Australia. Ellen AB is listed on First North as ELN. The company's Certified Advisers is Thenberg & Kinde. For more information, please contact: Anna Weiner Jiffer, Deputy Managing Director, Patent Manager Ellen AB, +46 8 412 10 00 Jane Walerud, Managing Director Ellen AB, +46 8 412 10 00 About Ellen AB Ellen AB is a biotech company that offers patented probiotic products to promote women's vaginal health. Basically all women suffer bacterial imbalance once or more often in life. Bacterial imbalance is caused by a weakened lactic acid bacteria flora. ELLEN® contains LN® (Lacto Naturel), which is comprised of human lactic acid bacteria, a natural part of healthy women's defence against infections. Ellen AB was the first company in the world to launch in the Nordic countries tampons treated with lactic acid bacteria in 2002. The company is currently engaged in an international launch and the development of new products based on the same technology. Ellen AB is listed on First North as ELN. www.ellenab.com